OakChart

Kenvue Inc

KVUEConsumer Defensive·Household & Personal Products·USA·Large·NYSE·Oct 30 • 3:59 PM ET

19.310.00 (0.00%)
2026-11-12 06:13 CET
Market cap
37,090.07 USD m
Revenue, TTM
15,530.00 USD m
Net income, TTM
1,690.00 USD m
Free cash flow, TTM
2,338.00 USD m
EPS diluted, TTM
0.88
P/E
21.97
Compare

Price

KVUE against its 20, 50 and 200-day averages
2050200beatmiss
17.0018.0019.0020.0033.3M66.6MVolumeApr 26Jun 26Jul 26Aug 26Sep 26Oct 26KVUEclose 19.3120-day 18.6450-day 18.41200-day 18.1919.3152w high

4.1% under the 52-week high of 20.13 on 7 Jul 2026. 52-week low 14.02 on 30 Oct 2025. Last 15 sessions, 14.4% high to low

the line is the 50-bar volume average

Profile

KVUE
52-week range, 86% of the way up
14.0620.13

Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. Its brands include Aveeno, BAND-AID Brand, Johnson's, Listerine, Neutrogena, and Tylenol. It operates through the following segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care, and others. The Essential Health segment focuses on oral care, baby care, women's health, and wound care. The company was founded on February 23, 2022 and is headquartered in Summit, NJ.

Employees22000
IPOMay 04, 2023
Beta0.39
ATR, 14d0.38
Rel volume0.00
Short float2.73%
Insider own0.25%
Inst own95.48%

Snapshot

6 groups

Valuation

Index-
Market Cap37.09B
Enterprise Value44.39B
Income1.69B
Sales15.53B
Book/sh5.29
Cash/sh0.54
Dividend Est.0.84 (4.34%)
Dividend TTM1.04 (5.41%)
Dividend Ex-DateSep 21, 2026
Dividend Gr. 3/5Y- -
Payout107.98%
Employees22000
IPOMay 04, 2023

Ratios

P/E21.97
Forward P/E15.53
PEG2.15
P/S2.39
P/B3.65
P/C35.70
P/FCF15.86
EV/EBITDA12.40
EV/Sales2.86
Quick Ratio0.66
Current Ratio0.96
Debt/Eq0.82
LT Debt/Eq0.71
Option/ShortNo / No

Earnings

EPS (ttm)0.88
EPS next Y1.24
EPS next Q0.26
EPS this Y8.37%
EPS next Y6.26%
EPS next 5Y7.21%
EPS past 3/5Y-10.84% -
Sales past 3/5Y0.43% 0.89%
EPS Y/Y TTM16.81%
Sales Y/Y TTM3.50%
EPS Q/Q7.87%
Sales Q/Q3.27%
EarningsOct 30 BMO
EPS/Sales Surpr.-0.55% 0.61%

Ownership

Insider Own0.25%
Insider Trans-0.87%
Inst Own95.48%
Inst Trans0.95%
ROA6.27%
ROE16.25%
ROIC9.75%
Gross Margin58.62%
Oper. Margin19.42%
Profit Margin10.88%
SMA203.57%
SMA504.91%
SMA2006.15%
Trades-

Technical

Shs Outstand1.92B
Shs Float1.92B
Short Float2.73%
Short Ratio2.31
Short Interest52.38M
52W High20.13 -4.07%
52W Low14.06 37.34%
Volatility1.89% 1.76%
ATR (14)0.38
RSI (14)59.98
Beta0.39
Rel Volume0.00
Avg Volume22.71M
Volume0

Performance

Perf Week-
Perf Month8.73%
Perf Quarter0.57%
Perf Half Y12.33%
Perf YTD11.94%
Perf Year35.60%
Perf 3Y3.59%
Perf 5Y-
Perf 10Y-
Recom2.71
Target Price19.67
Prev Close19.31
Price19.31
Change %0.00%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Jan 30, 2026DowngradeJJefferiesBuy → Hold$18-6.8%
Oct 29, 2025DowngradeCCanaccord GenuityBuy → Hold$15-22.3%
Sep 26, 2025UpgradeRRothschild & Co RedburnNeutral → Buy$22+13.9%
Apr 10, 2025InitiatedRRedburn AtlanticNeutral$23.50+21.7%
Mar 24, 2025InitiatedEEvercore ISIIn-line$25+29.5%
Jan 06, 2025UpgradePPiper SandlerNeutral → Overweight$21 → $26+34.6%
Dec 12, 2024DowngradeDDeutsche BankBuy → Hold$25 → $24+24.3%
Sep 24, 2024InitiatedJJefferiesBuy$27+39.8%
Sep 24, 2024DowngradeRRBC Capital MktsOutperform → Sector Perform$24+24.3%
May 28, 2024ResumedCCitigroupNeutral$21+8.8%

Peers

Mkt cap
TickerCompanyMkt cap
CHDChurch & Dwight Co Inc26.44B
HLNHaleon plc ADR40.00B
PGProcter & Gamble Co388.62B
CLColgate-Palmolive Co77.90B
KMBKimberly-Clark Corp66.80B
ULUnilever plc ADR141.71B
ELEstee Lauder Cos. Inc40.70B
EPCEdgewell Personal Care Co1.34B
PBHPrestige Consumer Healthcare Inc2.09B
PRGOPerrigo Company plc2.30B

Insider trading

latest 14 of 30
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Dasgupta AnindyaGroup President APACJul 31 '26Option Exercise0.0016,419016,419Aug 04 04:30 PM
Howlett HeatherCFO & CAOJun 10 '26Sale18.113,70066,98829,288Jun 12 04:11 PM
Howlett HeatherOfficerJun 10 '26Proposed Sale18.113,70066,988Jun 10 01:24 PM
Curado Gomes de Lemos LeonardoGroup President LATAMMay 01 '26Option Exercise0.0024,248024,248May 26 05:10 PM
Orlando MatthewGeneral CounselMay 08 '26Sale17.6638,491679,6910May 12 04:27 PM
Orlando MatthewOfficerMay 08 '26Proposed Sale17.6638,492679,691May 08 04:12 PM
Stevens MeredithChief Operations OfficerMar 10 '26Option Exercise0.005,170094,877Mar 12 07:14 PM
Alvarado LuaniChief People OfficerMar 10 '26Option Exercise0.004,222062,797Mar 12 07:14 PM
Lawson CarltonGroup President EMEA & LAMar 10 '26Option Exercise0.006,1580111,415Mar 12 07:14 PM
Lawson CarltonGroup President EMEA & LAMar 05 '26Option Exercise0.007,7360105,257Mar 09 05:03 PM
Alvarado LuaniChief People OfficerMar 05 '26Option Exercise0.004,289061,365Mar 09 05:03 PM
Stevens MeredithChief Operations OfficerMar 05 '26Option Exercise0.006,178092,224Mar 09 05:02 PM
Howlett HeatherVP & Chief Accounting OfficerMar 05 '26Option Exercise0.002,723033,921Mar 09 05:02 PM
Howlett HeatherVP & Chief Accounting OfficerMar 03 '26Option Exercise0.001,534031,724Mar 04 05:14 PM

Held by

AUM
TickerCompanyAUM
HDViShares Core High Dividend ETFAUM: 16.41B
HDViShares Core High Dividend ETFAUM: 16.41B
FLSPFranklin Systematic Style Premia ETFAUM: 1.21B
FLSPFranklin Systematic Style Premia ETFAUM: 1.21B
FLSPFranklin Systematic Style Premia ETFAUM: 1.21B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-300.2900.2920.2203,8863,86211
2026Q22026-08-060.3100.3190.2373,9553,96610
2026Q12026-05-070.3200.2620.2473,9093,84510
2025Q42026-02-170.2700.2200.1723,7803,67610
2025Q32025-11-030.2800.2600.2073,7643,82013
2025Q22025-08-070.2900.2820.2183,8393,85313
2025Q12025-05-080.2400.2280.1673,7413,67713
2024Q42025-02-060.2600.2570.1523,6623,76011
2024Q32024-11-070.2800.2720.1993,8993,92010
2024Q22024-08-060.3200.2760.0304,0003,9289
2024Q12024-05-070.2800.2540.1543,8943,7919
2023Q42024-02-080.3100.2830.1713,6663,7837
2023Q32023-10-260.3100.3130.2293,9153,9067
2023Q22023-07-200.3200.3020.2254,0113,9597
2023Q12023-07-170.324-0.1753,851-5
2022Q42023-05-290.280-0.1963,767--

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2022FY1.353-1.07814,950-
2023FY1.2901.2490.86915,44415,567
2024FY1.1401.1420.53815,45515,557
2025FY1.0801.0310.76015,12415,015
2026FY-1.170--15,607
2027FY-1.244--16,065
2028FY-1.331--16,594
2029FY-1.484--17,174
2030FY-1.395--17,442

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-041003,8523,8523,852
2026Q4S2026-11-022003,8683,8523,884
2026Q4S2026-11-016003,9003,8524,002
2026Q4S2026-10-306003,9023,8524,002
2026Q4S2026-10-2810003,8793,7864,002
2026Q4S2026-10-2410003,8793,7864,002
2026Q4S2026-10-1410013,8793,7864,002
2026Q4S2026-08-2110013,8773,7864,002
2026Q4S2026-08-1010013,8783,7864,002
2026Q4S2026-08-0910003,8833,8324,002
2026Q4S2026-08-0710013,8823,8324,002
2026Q4S2026-08-0610013,8823,8324,002
2026Q4S2026-08-0410013,8883,8324,007
2026Q4S2026-07-1410013,8883,8324,007

Estimate history

EPS, annual0.76-0.4651.0751.0780.8690.5380.7640.8789
Period2019202020212022202320242025TTM
EPS, quarterly0.1990.1520.1670.2180.2070.1720.2470.2370.223
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual1431714469150431492915443154561512315530
Period2019202020212022202320242025TTM
Sales, quarterly390036623741383937633780390939553886
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual1888.9731888.9731888.9731914.8941915.0571913.7681916.1151920.88
Period2019202020212022202320242025MRQ
Shares, quarterly1916.2781913.7681918.8591918.8371915.7311916.1151919.9351920.2411920.88
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Total Revenue15,530.0015,123.0015,456.0015,443.0014,929.0015,043.0014,469.0014,317.00
Cost of Goods Sold Incl. D&A6,426.006,308.006,484.006,831.006,622.006,564.006,582.006,626.00
Gross Profit9,104.008,815.008,972.008,612.008,307.008,479.007,887.007,691.00
Selling, General and Administrative Excl. Other6,088.006,079.006,024.005,673.005,375.005,416.004,908.005,150.00
Research and Development372.00382.00408.00399.00375.00355.00320.00391.00
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income3,016.002,736.002,948.002,939.002,932.003,063.002,979.002,541.00
Interest Expense422.00430.00431.00358.00----
Unusual Expense344.00401.001,158.00481.00306.00117.0066.00122.00
Net Income Before Taxes2,306.001,999.001,415.002,190.002,637.002,925.00-1,016.002,120.00
Income Taxes616.00529.00385.00526.00573.00894.00-137.00685.00
Consolidated Net Income1,690.001,470.001,030.001,664.002,064.002,031.00-879.001,435.00
Net Income From Continuing Operations1,690.001,470.001,030.001,664.002,064.002,031.00-879.001,435.00
Net Income1,690.001,470.001,030.001,664.002,064.002,031.00-879.001,435.00
EPS (Recurring)1.000.910.961.041.191.12-0.440.80
EPS (Basic, Before Extraordinaries)0.880.770.540.871.081.08-0.470.76
EPS (Diluted)0.880.760.540.871.081.08-0.470.76
EBITDA3,581.003,293.003,570.003,566.003,576.003,794.003,725.003,250.00
Non-Operating Income (Expense)56.0094.0056.0090.0011.00-21.00-3,929.00-299.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense94.80107.44200.66114.55654.12102.9383.9574.46
Price To Earnings Ratio22.3922.3938.5226.1326.13---
Price To Sales Ratio2.212.192.672.67----
Gross Margin58.6258.2958.0555.7755.6456.3754.5153.72
Operating Margin19.4218.0919.0719.0319.6420.3620.5917.75
Net Margin10.889.726.6610.7813.8313.50-6.0810.02
Shares Outstanding1,920.881,916.121,913.771,915.061,914.891,888.971,888.971,888.97
Market Capitalization37,090.0737,090.0740,933.5041,228.0141,228.01---

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue3,886.003,955.003,909.003,780.003,763.003,839.003,741.003,662.00
Cost of Goods Sold Incl. D&A1,554.001,645.001,603.001,624.001,543.001,585.001,556.001,587.00
Gross Profit2,332.002,310.002,306.002,156.002,220.002,254.002,185.002,075.00
Selling, General and Administrative Excl. Other1,567.001,536.001,451.001,534.001,507.001,502.001,536.001,458.00
Research and Development96.0094.0084.0098.0094.0091.0099.00106.00
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income765.00774.00855.00622.00713.00752.00649.00617.00
Interest Expense104.00103.00106.00109.00107.00107.00107.00108.00
Unusual Expense47.0084.0084.00129.00104.0084.0079.00153.00
Net Income Before Taxes609.00598.00672.00427.00526.00588.00458.00346.00
Income Taxes179.00142.00198.0097.00128.00168.00136.0053.00
Consolidated Net Income430.00456.00474.00330.00398.00420.00322.00293.00
Net Income From Continuing Operations430.00456.00474.00330.00398.00420.00322.00293.00
Net Income430.00456.00474.00330.00398.00420.00322.00293.00
EPS (Recurring)0.240.270.280.220.240.250.200.21
EPS (Basic, Before Extraordinaries)0.220.240.250.170.210.220.170.15
EPS (Diluted)0.220.240.250.170.210.220.170.15
EBITDA906.00917.00998.00760.00854.00894.00785.00765.00
Non-Operating Income (Expense)-5.0011.007.0043.0024.0027.00-5.00-14.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense22.9125.2822.9123.7019.7529.2334.7642.66
Price To Earnings Ratio22.3922.6622.5723.1922.0538.1744.8038.52
Price To Sales Ratio2.212.392.202.182.102.662.982.69
Gross Margin60.0158.4158.9957.0459.0058.7158.4156.66
Operating Margin19.6919.5721.8716.4618.9519.5917.3516.85
Net Margin11.0711.5312.138.7310.5810.948.618.00
Shares Outstanding1,920.881,920.241,919.931,916.121,915.731,918.841,918.861,913.77
Market Capitalization37,090.0736,691.3933,044.4333,051.1731,146.5140,183.7245,831.5440,933.50

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Cash & Short Term Investments1,062.001,070.001,382.001,231.00740.00618.00-
Short Term Receivables2,382.002,165.002,073.002,122.002,074.001,858.00-
Inventories1,666.001,591.001,851.002,226.001,702.001,685.00-
Other Current Assets587.00699.00832.00298.00411.00434.00-
Total Current Assets5,697.005,525.006,138.005,877.004,927.004,595.00-
Net Property, Plant & Equipment2,540.001,960.002,181.001,930.001,953.002,113.00-
Total Investments and Advances0.0036.0071.0066.0074.00122.00-
Intangible Assets18,203.0017,317.0018,890.0019,038.0020,511.0021,936.00-
Deferred Tax Assets237.00184.00158.00147.00189.00193.00-
Other Assets399.00579.00413.00258.00275.00218.00-
Total Assets27,076.0025,601.0027,851.0027,316.0027,929.0029,177.00-
Short Term Debt Incl. Current Port. of LT Debt1,496.001,588.00643.0035.00129.00160.00-
Accounts Payable2,414.002,267.002,459.001,829.001,827.001,579.00-
Income Tax Payable105.0074.00142.00329.00357.00393.00-
Other Current Liabilities1,930.001,810.002,237.001,733.001,729.005,362.00-
Total Current Liabilities5,945.005,739.005,481.003,926.004,042.007,494.00-
Long Term Debt7,178.007,131.007,784.0081.00129.00160.00-
Provision for Risks Charges135.00143.00141.000.000.000.00-
Deferred Tax Liabilities2,354.002,261.002,621.002,479.002,430.001,756.00-
Other Liabilities699.00659.00613.00860.00929.001,411.00-
Total Liabilities16,311.0015,933.0016,640.007,346.007,530.0010,821.00-
Non-Equity Reserves0.000.000.000.000.000.00-
Preferred Stock - Carrying Value0.000.000.000.000.000.00-
Common Equity10,765.009,668.0011,211.0019,970.0020,399.0018,356.00-
Total Shareholders Equity10,765.009,668.0011,211.0019,970.0020,399.0018,356.00-
Accumulated Minority Interest0.000.000.000.000.000.00-
Total Equity10,765.009,668.0011,211.0019,970.0020,399.0018,356.00-
Total Liabilities & Stockholders Equity27,076.0025,601.0027,851.0027,316.0027,929.0029,177.00-
Book Value Per Share5.625.055.8510.4310.809.72-
Tangible Book Value Per Share-3.88-4.00-4.010.49-0.06-1.90-
Full-Time Employees22,00022,00022,00022,20020,000--
Price to Book Ratio3.513.843.783.78---
Return on Assets5.583.856.037.477.11--
Return on Equity14.399.8710.6610.2310.48--
Return on Invested Capital8.196.138.7610.299.89-4.75-
Quick Ratio0.680.690.780.930.800.39-
Current Ratio0.960.961.121.501.220.61-

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Net Income1,690.001,470.001,030.001,664.002,064.002,031.00-879.001,435.00
Depreciation569.00557.00622.00627.00644.00731.00746.00709.00
Other Funds (Non Cash)203.00226.00973.00194.00150.00136.0089.00-47.00
Funds from Operations2,370.002,145.002,340.002,371.003,038.003,466.00-845.002,194.00
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital361.0052.00-571.00797.00-513.00-3,132.004,242.00804.00
Income Taxes Payable85.00-27.00-61.00-331.00-5.00-19.00-96.00162.00
Cash from Operating Activities2,731.002,197.001,769.003,168.002,525.00334.003,397.002,998.00
Capital Expenditures-393.00-475.00-440.00-469.00-375.00-295.00-229.00-289.00
Net Assets From Acquisitions0.000.000.000.000.000.000.00-1,929.00
Sale of Fixed Assets and Businesses24.0024.000.0021.008.0059.00176.0083.00
Purchase or Sale of Investments0.000.000.000.000.0065.00-30.00-20.00
Purchase of Investments0.000.000.000.000.00-12.00-30.00-20.00
Sale Or Maturity of Investments0.000.000.000.000.0077.000.000.00
Other Uses-41.000.000.00-8,981.00-23.000.000.000.00
Other Sources11.0015.0015.008,941.000.000.000.000.00
Cash from Investing Activities-399.00-436.00-425.00-488.00-390.00-171.00-83.00-2,155.00
Cash Dividends Paid-1,597.00-1,581.00-1,552.00-14,554.000.000.000.000.00
Change in Capital Stock0.00-197.00-235.004,241.000.000.000.000.00
Repurchase of Common Pref Stock0.00-197.00-235.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.004,241.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.004,241.000.000.000.000.00
Issuance or Reduction of Debt, Net-836.00-150.00159.008,246.0014.00-7.00-11.00-40.00
Change in Long Term Debt-750.00-4.000.007,686.000.00-7.00-11.00-40.00
Issuance of Long Term Debt0.00746.000.007,686.000.000.000.000.00
Reduction of Long Term Debt-750.00-750.000.000.000.00-7.00-11.00-40.00
Net Financing Active Other Cash Flow3.0091.0063.00-460.00-1,597.007.00-3,446.00-645.00
Other Financing Activities Uses0.000.000.00-460.00-1,597.000.00-3,446.00-645.00
Cash from Financing Activities-2,430.00-1,837.00-1,565.00-2,527.00-1,583.000.00-3,457.00-685.00
Exchange Rate Effect-2.0068.00-91.00-2.00-61.00-41.009.00-11.00
Net Change in Cash-100.00-8.00-312.00151.00491.00122.00-134.00147.00
Free Cash Flow2,338.001,722.001,329.002,699.002,150.0039.003,168.002,709.00
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.00
Price to Free Cash Flow46.27234.56------
Deferred Taxes & Investment Tax Credit--108.00-285.00-114.00180.00568.00-801.0097.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments1,039.001,110.001,075.001,062.001,139.001,070.00
Short Term Receivables2,504.002,476.002,501.002,382.002,416.002,331.00
Inventories1,815.001,722.001,674.001,666.001,794.001,776.00
Other Current Assets581.00591.00545.00587.00683.00677.00
Total Current Assets5,939.005,899.005,795.005,697.006,032.005,854.00
Net Property, Plant & Equipment2,233.002,226.002,208.002,540.002,092.002,038.00
Total Investments and Advances8.0017.009.000.001.000.00
Intangible Assets17,581.0017,671.0017,916.0018,203.0018,157.0018,290.00
Deferred Tax Assets244.00247.00232.00237.00237.00220.00
Other Assets666.00675.00694.00399.00729.00730.00
Total Assets26,671.0026,735.0026,854.0027,076.0027,248.0027,132.00
Short Term Debt Incl. Current Port. of LT Debt1,162.001,447.001,631.001,496.001,951.001,591.00
Accounts Payable2,639.002,530.002,480.002,414.002,403.002,510.00
Income Tax Payable118.0075.0096.00105.00103.0089.00
Other Current Liabilities2,297.001,815.001,689.001,930.001,699.001,798.00
Total Current Liabilities6,216.005,867.005,896.005,945.006,156.005,988.00
Long Term Debt7,179.007,166.007,171.007,178.007,158.007,153.00
Provision for Risks Charges125.00133.00129.00135.00151.00154.00
Deferred Tax Liabilities2,297.002,328.002,354.002,354.002,425.002,380.00
Other Liabilities692.00688.00696.00699.00724.00727.00
Total Liabilities16,509.0016,182.0016,246.0016,311.0016,614.0016,402.00
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity10,162.0010,553.0010,608.0010,765.0010,634.0010,730.00
Total Shareholders Equity10,162.0010,553.0010,608.0010,765.0010,634.0010,730.00
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity10,162.0010,553.0010,608.0010,765.0010,634.0010,730.00
Total Liabilities & Stockholders Equity26,671.0026,735.0026,854.0027,076.0027,248.0027,132.00
Book Value Per Share5.295.505.535.625.555.59
Tangible Book Value Per Share-3.86-3.71-3.81-3.88-3.93-3.94
Full-Time Employees---22,000--
Price to Book Ratio3.513.463.073.112.904.00
Return on Assets6.276.166.115.585.295.29
Return on Equity16.2515.5815.7014.3913.4713.56
Return on Invested Capital2.482.572.671.842.242.35
Quick Ratio0.660.710.700.680.690.68
Current Ratio0.961.010.980.960.980.98

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income430.00456.00474.00330.00398.00420.00
Depreciation143.00145.00143.00138.00141.00142.00
Other Funds (Non Cash)43.0047.0047.0066.0046.0054.00
Funds from Operations603.00638.00692.00437.00601.00602.00
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital97.0050.00-203.00417.00-307.0019.00
Income Taxes Payable47.00-48.0033.0053.00-51.00-91.00
Cash from Operating Activities700.00688.00489.00854.00294.00621.00
Capital Expenditures-80.00-64.00-139.00-110.00-98.00-88.00
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.0024.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses1.00-14.00-28.000.000.000.00
Other Sources0.000.000.0011.00-6.00-2.00
Cash from Investing Activities-79.00-78.00-167.00-75.00-104.00-90.00
Cash Dividends Paid-403.00-398.00-398.00-398.00-398.00-393.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.000.000.000.00-70.00-64.00
Repurchase of Common Pref Stock0.000.000.000.00-70.00-64.00
Sale of Common Pref Stock0.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-296.00-190.00120.00-470.00349.00-147.00
Change in Long Term Debt0.000.00-750.000.000.00746.00
Issuance of Long Term Debt0.000.000.000.000.00746.00
Reduction of Long Term Debt0.000.00-750.000.000.000.00
Net Financing Active Other Cash Flow20.001.00-17.00-1.009.0056.00
Other Financing Activities Uses16.001.00-17.000.000.000.00
Cash from Financing Activities-679.00-587.00-295.00-869.00-110.00-548.00
Exchange Rate Effect-13.0012.00-14.0013.00-11.0030.00
Net Change in Cash-71.0035.0013.00-77.0069.0013.00
Free Cash Flow620.00624.00350.00744.00196.00533.00
Price to Free Cash Flow46.27114.25142.68234.08553.96718.87

Revenue breakdown

Asia Pacific2024: 2.97B 2025: 2.78B
EMEA2024: 3.56B 2025: 3.72B
Latin America2024: 1.34B 2025: 1.37B
North America2024: 7.58B 2025: 7.26B
Essential Health2024: 4.69B 2025: 4.63B
Self Care2024: 6.53B 2025: 6.38B
Skin Health and Beauty2024: 4.24B 2025: 4.11B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-302.73%52.4M1916.0M22.71M
2026-10-152.91%55.7M1916.0M22.27M
2026-09-303.01%57.7M1916.1M21.99M
2026-09-153.01%57.6M1916.0M22.81M
2026-08-313.77%72.1M1915.3M20.63M
2026-08-142.76%52.8M1915.3M20.37M
2026-07-313.30%63.3M1918.1M20.60M
2026-07-153.21%61.6M1917.3M20.21M
2026-06-303.06%58.6M1917.3M20.28M
2026-06-153.58%68.6M1917.3M19.36M
2026-05-293.64%69.7M1917.3M20.91M
2026-05-153.20%61.3M1917.3M23.34M
2026-04-302.97%57.0M1918.2M30.81M
2026-04-153.15%60.3M1915.0M37.59M
2026-03-313.22%61.7M1915.1M41.50M
2026-03-133.04%58.2M1915.1M43.40M
2026-02-273.49%66.8M1915.1M43.90M
2026-02-133.09%59.2M1915.1M45.06M
2026-01-302.74%52.5M1914.8M44.37M
2026-01-153.88%74.3M1914.8M41.23M

Option chain

expiry 2026-11-12
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-04EFFECTEffectiveness filing by commission orderSEC
2026-11-048-KCurrent report2026-11-04SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-02POS AMPost-effective amendment to a registration statement that is not immediately effective upon filingSEC
2026-11-02S-8 POSPost-effective amendment to a S-8 registration statementSEC
2026-11-02S-8 POSPost-effective amendment to a S-8 registration statementSEC
2026-11-02POSASRPost-effective amendment to an automatic shelf registration statement of Form S-3ASR or Form F-3ASRSEC
2026-11-024Statement of changes in beneficial ownership of securities2026-10-29SEC
2026-11-028-KCurrent report2026-11-01SEC
2026-11-024Statement of changes in beneficial ownership of securities2026-10-29SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060066.99K1
2026-0500679.69K1
2026-040000
2026-030000
2026-020000
2026-010000
2025-12110.99M200
2025-110000

Institutional holders

Manager% owned
FMR LLC8.86%
BlackRock, Inc.7.86%
VANGUARD CAPITAL MANAGEMENT LLC6.53%
STATE STREET CORP6.33%
VANGUARD PORTFOLIO MANAGEMENT LLC4.86%
GEODE CAPITAL MANAGEMENT, LLC2.75%
Pentwater Capital Management LP2.66%
Independent Franchise Partners LLP2.63%
NORGES BANK2.40%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/2.33%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND3.17%
VANGUARD 500 INDEX FUND2.59%
VANGUARD MID-CAP INDEX FUND2.17%
VANGUARD WELLINGTON FUND2.03%
VANGUARD INTERMEDIATE-TERM CORPORATE BOND INDEX FUND1.93%
Goldman Sachs Tactical Tilt Overlay Fund1.52%
iShares Core S&P 500 ETF1.38%
VANGUARD WELLESLEY INCOME FUND1.34%
Fidelity 500 Index Fund1.30%
VANGUARD SHORT-TERM CORPORATE BOND INDEX FUND1.26%

OakChart. KVUE. Cached 15 minutes.